Immutep Ltd ADR (IMMP)vsInsmed Inc (INSM)
IMMP
Immutep Ltd ADR
$0.36
-6.28%
HEALTHCARE · Cap: $58.17M
INSM
Insmed Inc
$148.31
+6.59%
HEALTHCARE · Cap: $29.99B
Smart Verdict
WallStSmart Research — data-driven comparison
Insmed Inc generates 7554% more annual revenue ($606.42M vs $7.92M). IMMP leads profitability with a 0.0% profit margin vs -2.1%. INSM earns a higher WallStSmart Score of 39/100 (F).
IMMP
Hold35
out of 100
Grade: F
INSM
Hold39
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 91.5% year-over-year
Conservative balance sheet, low leverage
No standout strengths identified
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Weak financial health signals
1.5% revenue growth
0.0% earnings growth
Trading at 43.0x book value
ROE of -2.5% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : IMMP
The strongest argument for IMMP centers on Revenue Growth, Debt/Equity. Revenue growth of 91.5% demonstrates continued momentum.
Bull Case : INSM
PEG of 1.09 suggests the stock is reasonably priced for its growth.
Bear Case : IMMP
The primary concerns for IMMP are EPS Growth, Market Cap, Profit Margin.
Bear Case : INSM
The primary concerns for INSM are Revenue Growth, EPS Growth, Price/Book.
Key Dynamics to Monitor
IMMP profiles as a hypergrowth stock while INSM is a turnaround play — different risk/reward profiles.
IMMP carries more volatility with a beta of 1.64 — expect wider price swings.
IMMP is growing revenue faster at 91.5% — sustainability is the question.
IMMP generates stronger free cash flow (-28M), providing more financial flexibility.
Bottom Line
INSM scores higher overall (39/100 vs 35/100). Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Immutep Ltd ADR
HEALTHCARE · BIOTECHNOLOGY · USA
Immutep Limited, a biotechnology company, is dedicated to the research and development of pharmaceutical candidates. The company is headquartered in Sydney, Australia.
Visit Website →Insmed Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Insmed Incorporated, a biopharmaceutical company, develops and markets therapies for patients with rare and serious diseases. The company is headquartered in Bridgewater, New Jersey.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?